Cargando…

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers

Triple-negative breast cancers (TNBCs) lack ER, PR and her2 receptors that are targets of common breast cancer therapies with poor prognosis due to their high rates of metastasis and chemoresistance. Based on our previous studies that epigenetic silencing of a potential metastasis suppressor, arrest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soung, Young Hwa, Chung, Heesung, Yan, Cecilia, Fesler, Andrew, Kim, Hyungjin, Oh, Eok-Soo, Ju, Jingfang, Chung, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463492/ https://www.ncbi.nlm.nih.gov/pubmed/32784600 http://dx.doi.org/10.3390/cancers12082209

Ejemplares similares

Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b
por: Soung, Young Hwa, et al.
Publicado: (2019)

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
por: Fesler, Andrew, et al.
Publicado: (2017)

Expression and predictive value of miR-489 and miR-21 in melanoma metastasis
por: Mo, Hao, et al.
Publicado: (2019)

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer
por: Fesler, Andrew, et al.
Publicado: (2014)

THU489 The Role Of Noncoding Genes With The Bidirectional Promoter In Triple-negative Breast Cancer
por: Yang, Barbara, et al.
Publicado: (2023)

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer
por: Hwang, Ga-Ram, et al.
Publicado: (2023)

Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells
por: Wu, Ning, et al.
Publicado: (2017)

Expression of miR-221 and miR-489 in breast cancer patients and their relationship with prognosis
por: Li, Fanfan
Publicado: (2020)

miR-489 Suppresses Proliferation and Invasion of Human Bladder Cancer Cells
por: Li, Jing, et al.
Publicado: (2016)

Extracellular Vesicles from Korean Codium fragile and Sargassum fusiforme Negatively Regulate Melanin Synthesis
por: Jang, Bohee, et al.
Publicado: (2021)

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake
por: Fesler, Andrew, et al.
Publicado: (2022)

Circulating miR-489 as a potential new biomarker for idiopathic dilated cardiomyopathy
por: Ishiguro, Tomoya, et al.
Publicado: (2021)

Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy
por: Zhai, Haiyan, et al.
Publicado: (2015)

miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer
por: Soni, Mithil, et al.
Publicado: (2022)

miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1
por: Bai, Peide, et al.
Publicado: (2020)

miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential
por: Yang, Xuhui, et al.
Publicado: (2019)

miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]
Publicado: (2020)

489 Accuracy of Clinicians' Empiric Treatment Choices for Resistant Gram-Negative Uropathogens
por: Linsenmeyer, Katherine, et al.
Publicado: (2014)

Development of microRNA-based therapy for pancreatic cancer
por: Fesler, Andrew, et al.
Publicado: (2019)

Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip)
por: Fesler, Andrew, et al.
Publicado: (2015)

miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF
por: Wu, Qiuyun, et al.
Publicado: (2016)

Séminaire Bourbaki : exposés 489–506
por: Borho, Walter, et al.
Publicado: (1978)

SUN-489 MetastaticThyroidCancer
por: Vásquez, Romyna La Rosa
Publicado: (2020)

Screening of breast cancer stem cell inhibitors using a protein kinase inhibitor library
por: Choi, Hack Sun, et al.
Publicado: (2017)

Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2
por: Chen, Lu, et al.
Publicado: (2019)

Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis
por: Patel, Y, et al.
Publicado: (2018)

Effects of miR-489 targeting on SOX4 gene on proliferation and apoptosis of human hepatocellular carcinoma cells
por: Wang, Bing, et al.
Publicado: (2020)

Long noncoding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p
por: Yin, Chong, et al.
Publicado: (2022)

miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC)
por: Kikkawa, N, et al.
Publicado: (2010)

MiR-489 aggravates H(2)O(2)-induced apoptosis of cardiomyocytes via inhibiting IGF1
por: Tang, Shan, et al.
Publicado: (2020)

Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer
por: Mao, Shun-Hong, et al.
Publicado: (2021)

miR-489-3p inhibits TLR4/NF-κB signaling to prevent inflammation in psoriasis
por: Ye, Yujian, et al.
Publicado: (2021)

Ginsenoside Re inhibits myocardial fibrosis by regulating miR-489/myd88/NF-κB pathway
por: Sun, Jinghui, et al.
Publicado: (2023)

SAT489 Grave’s Disease Secondary To Alemtuzumabuse
por: Gong, Michael Shifeng, et al.
Publicado: (2023)

Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer
por: Wu, Song, et al.
Publicado: (2016)

The expanding regulatory universe of p53 in gastrointestinal cancer
por: Fesler, Andrew, et al.
Publicado: (2016)

Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
por: Guo, Shixiang, et al.
Publicado: (2019)

Selective Inhibitors of Nuclear Export (SINE) compounds block proliferation and migration of triple negative breast cancer cells by restoring expression of ARRDC3
por: Soung, Young Hwa, et al.
Publicado: (2017)

(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression
por: Park, Jisu, et al.
Publicado: (2015)

Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP
por: Wang, Xuedong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p6tjpjrlj4hbh5hpblbdfo8q60